Elekta AB Overview
Pro stress-test →Elekta AB is a Swedish medical technology company specializing in advanced cancer care and neuroscience solutions. The company develops and provides radiotherapy systems, clinical software, and comprehensive treatment solutions for oncology and neurological disorders, serving healthcare providers globally across North America, Europe, Asia-Pacific, and other regions.
Strategic Profile
Pro stress-test →Elekta operates through four core product lines: Oncology (linear accelerators and imaging systems), Brachytherapy (internal radiation treatment), Neuroscience (neurological diagnosis and treatment), and Software (clinical workflow and treatment planning solutions). The company is undergoing strategic restructuring with 450-employee reduction targeting over SEK 500 million in annual cost savings while managing near-term headwinds in key markets like China and FX pressures.
Competitive Landscape
Pro stress-test →Elekta competes in the specialized medical radiation therapy and oncology software markets against established players including Siemens Healthineers, Stryker, and other healthcare equipment manufacturers. The company differentiates through integrated treatment solutions and specialized software platforms. Market consolidation and globalization are ongoing trends, with Elekta positioned as a specialized focused player rather than diversified conglomerate.
Industry Context
Elekta AB operates in Medical Devices - Oncology & Radiation Therapy.
Key facts
Founded: 1972 · Headquarters: Stockholm, Sweden · Employees: Approximately 3,900 (post-reduction: ~3,450) · Revenue: $1.74B (TTM) · Market cap: $2.34B